PulmCCM

Home
Index
Reviews
Physiology
All
Book
About

Cardiac arrest, ECMO, Resuscitation

Are usual vasopressor doses causing unrecognized harm?
Two meta-analyses suggest "permissive hypotension" might save lives in vasodilatory shock
 • 
PulmCCM
8
More data on Impella complications emerge
Six months later, DanGer-Shock post hocs add detail on AKI and bleeding
 • 
PulmCCM
Intraosseous vs intravenous access: which is better during resuscitation?
Two randomized trials shed light on expanding use of IOs by EMTs
 • 
PulmCCM
2
ABC-SEPSIS trial for albumin in septic shock
Neither of two large randomized trials in the 2000s showed a benefit from albumin solutions as a resuscitation fluid for patients with septic shock.
 • 
PulmCCM
Does preventing fevers after strokes protect the brain?
And what about fevers in post-cardiac arrest patients?
 • 
PulmCCM
Can early steroids improve STEMI outcomes?
PULSE-MI trial tests high-dose methylprednisolone given pre-hospital
 • 
PulmCCM
Albumin as resuscitation fluid for septic shock: Review
ABC-SEPSIS trial adds to aging body of evidence
 • 
PulmCCM
6
Many "vegetative" patients are conscious and responsive
"Cognitive-motor dissociation" complicates the prognosis of unresponsive patients
 • 
PulmCCM
6
Resuscitative TEE challenges standardized CPR
TEE's diffusion from cardiac PACU into ED/ICUs tries to build its use case
 • 
PulmCCM
Can a gut hormone protect the brain after cardiac arrest? (GRECO trial)
Ghrelin's intriguing phase 2 results need confirmation in larger phase 3 trials
 • 
PulmCCM
2
Impella saves lives in STEMI with shock, but with major risks (DanGer Shock)
What’s more dangerous than an Impella? Cardiogenic shock
 • 
PulmCCM
Extracorporeal CO2 removal for COPD exacerbations (VENT-AVOID trial)
Extracorporeal membrane oxygenation (ECMO) is a sometimes life-saving technology for acute respiratory or cardiac failure.
 • 
PulmCCM
© 2024 PulmCCM LLC
Substack
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture